INmune Bio Inc.
INMB
$1.21
-$0.01-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.45% | 18.30% | -17.34% | 7.42% | -25.63% |
| Total Receivables | -45.62% | 222.29% | 73.52% | -36.86% | -47.36% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 235.27% | 79.76% | -46.30% | -50.15% | -81.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.88% | 31.88% | -14.45% | 1.52% | -29.72% |
|
|
|||||
| Total Current Assets | 8.88% | 31.88% | -14.45% | 1.52% | -29.72% |
| Net Property, Plant & Equipment | 732.01% | 508.79% | 479.70% | 197.52% | -28.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,293.88% | 653.16% | 809.76% | 603.70% | -53.77% |
| Total Assets | -31.70% | -18.23% | -36.80% | -28.16% | -19.29% |
|
|
|||||
| Total Accounts Payable | -35.27% | 18.79% | -35.08% | -17.36% | -22.55% |
| Total Accrued Expenses | -- | 0.00% | -54.55% | 32.37% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 382.19% | 345.00% | -82.62% | -95.69% | -98.07% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -1.92% | 12.12% |
| Total Other Current Liabilities | -- | -- | -- | -1.92% | 12.12% |
| Total Current Liabilities | -32.03% | 16.55% | -46.78% | -42.95% | -54.57% |
|
|
|||||
| Total Current Liabilities | -32.03% | 16.55% | -46.78% | -42.95% | -54.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 301.00% | 68.44% | 119.37% | -28.26% | -44.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -23.79% | 18.25% | -43.43% | -42.65% | -54.36% |
|
|
|||||
| Common Stock & APIC | 15.59% | 19.17% | 18.76% | 26.93% | 26.21% |
| Retained Earnings | -24.07% | -28.16% | -32.42% | -39.15% | -30.90% |
| Treasury Stock & Other | -19.18% | -28.17% | 26.25% | -7.01% | 8.82% |
| Total Common Equity | -33.87% | -26.71% | -34.38% | -20.43% | 5.13% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.87% | -26.71% | -34.38% | -20.43% | 5.13% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.87% | -26.71% | -34.38% | -22.15% | 2.24% |
|
|
|||||